Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in MiceDavid M. Alvarado, Matthew A. Ciorba, Larissa B. Thackray et al.|Inflammatory Bowel Diseases|2021Cited by 7